Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial
-
Published:2024-09
Issue:
Volume:50
Page:101160
-
ISSN:2666-6065
-
Container-title:The Lancet Regional Health - Western Pacific
-
language:en
-
Short-container-title:The Lancet Regional Health - Western Pacific
Author:
Cai Ming-Ci,
Cheng Shu,
Jing Hong-Mei,
Liu Yan,
Cui Guo-Hui,
Niu Ting,
Shen Jian-Zhen,
Huang Liang,
Wang Xin,
Huang Yao-Hui,
Wang Li,
Xu Peng-Peng,
Zhao Wei-LiORCID